UiPath, Inc. (NYSE:PATH) is one of the cheap AI stocks to buy in 2026. On February 23, 2026, UiPath announced a suite of agentic AI solutions for healthcare providers and payers, targeting ...

PATH pushes deeper into agentic AI with open standards, new platform tools, and partners, but real payoff may depend on adoption speed and future pricing models.

In addition to the Agentic ERP offering, the alliance includes UiPath’s support of a Deloitte SAP AI & Innovation Center in EMEA — an accelerator focused on integrating AI and emerging technologies ...

UiPath (PATH) heads into its fiscal fourth quarter report today, with investors weighing its history of meeting guidance against softer sector sentiment, fresh healthcare agentic AI launches, and new ...

UiPath Inc PATH reported financial results for the fourth quarter of fiscal 2026 after the market close on Wednesday. Here’s a look at the key details from the report. UiPath shares are advancing ...

It's still too early to say whether UiPath will ultimately end up, on net, as benefitting from or being harmed by AI adoption. Read why PATH stock is a Sell.

Will collaborate with other member organizations to develop and expand open protocols, tooling, and best practices for ...

UiPath reported top- and bottom-line gains in the fiscal fourth quarter, but its stock declined after the company guided for ...

UiPath works with a technology known as agentic automation, which is the process of using artificial intelligence to carry out multi-step tasks quickly with limited human input. U ...

UiPath, Inc. (NYSE: PATH) to report Q4 earnings on March 11. Analysts expect EPS of $0.26 and revenue of $464.49 million.